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Calcitonin {CT)-secreting cells (C-cells) are remarkably sensitive to changes in the extracelhdar Ca2+ concentration. In order to detect the mecha- 
nism by which C-cells monitor Ca*+, we compared a C-cell line responding to Ca2+ (rMTC cells) with another one known to have a defect in 
this Car+ signal transduction (TT cells). Rises of the Ca2+ concentration caused rMTC cells to depolarize and/or elicited spontaneous action poten- 
tials. Under voltage-clamp conditions, rMTC cells showed a slowly decaying Ca2+ inward current which was sensitive to dihydropyridines but 
not to Ni2+ at a low concentration. In contrast, the ‘defective’ TT cells neither depolarized nor fired action potentials with high Ca2+; they only 
exhibited an Ni2+-sensitive, transient Ca2+ current. The data strongly suggest hat the slowly inactivating Ca2+ current is a prerequisite for Ca*+- 
sensitivity of C-cells and that fast inactivating channels are not sufficient o act as sensors of the extracellular Ca2+ concentration. 
Calcitonin-secreting cell; rMTC cell; TT cell; Calcium current 
1. INTRODUCTION 
Calcitonin (CT)-secreting cells (C-cells) are preferen- 
tially located in the thyroid gland and are considered to 
play an important role in the complex regulatory net- 
work of Ca2+ homeostasis. Previous reports on the per- 
manent C-cell line rMTC [1,2] revealed a close correla- 
tion between the extracellular Ca2+ concentration and 
both the intracellular Ca2+ concentration [3] and CT 
release. The Ca2” -dependent CT release was blocked by 
nitrendipine [4] or verapamil [S], mimicked by Bay K 
8644 [4,6] and potentiated by (+)202-791 [7), In con- 
trast, C-cells of the TT-line IS], due to an unknown 
defect, are unable to respond to Ca2’, but CT secretion 
rises after electropermeabil~ation 191. Although these 
findings have suggested a prominent role of voltage- 
dependent Ca2+ channels [4,7,10] for the Ca2’ sen- 
sitivity of C-cells, no electrophysiological data suppor- 
ting this hypothesis are yet available. Here we report on 
whole cell recordings of voltage-dependent Ca2’ cur- 
rents in rMTC and TT cells. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
Rat MTC cells (rMTC 44-2 C-cell line) were grown in monolayer 
culture usinn DMEM (Biochrom. Berlin. FRG) supplemented with 
15% horse &urn and 2.5% fetal calf serum (Gibci, Paisley, UK). 
Human MTC cells (TT cells, hMTC C-cell line) were grown in the 
same way except for the use of RPMI-1640 medium (Gibco, Paisley, 
UK) supplemented with 16% fetal calf serum. 
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2.2. Secretion experiments 
Confluent rat and human C-cells were pr~ncubated with serum- 
free DMEM or RPM1 medium for 2 h, washed twice with PBS buffer 
and incubated again with medium containing test agents or vehicle for 
1 h. Then medium was removed and stored at - 2O*C until assayed 
for immumoreactive CT [12]. CT secretion was standardized to 
cellular protein content. 
2.3. Electrophysiology 
For electrophysiological investigations, cells were cultured on small 
glass slides (density 2-5 cells/mm2). After transfer into a chamber (0.2 
ml), the attached cells were superfused at a constant rate of about 5 
ml/min. The whole cell membrane currents were measured according 
to the method described by Hamill et al. [ 111 for special modifications 
(see 1131). The patch electrodes had an average resistance of 5 MB 
(open diameter about 1 hm), which allowed to obtain GQ seals within 
about 30 s. After disruption of the membrane patch under the tip of 
the patch pipette, a whole cell configuration was obtained, suitable 
for measuring membrane currents under voltage-clamp conditions 
(see [l 1 I). Or, alternatively and in order to avoid a major disturbance 
of the cytoplasma, e.g. change of the intracellular Ca*’ buffering 
capacity, we assessed the cytoplasma using the nystatin method 
[14,15]. 
2.4. Solutions 
External solution El contained (in mM): 135 NaCl, 1.2 CaCls, 1 
MgClr, 5.4 KC!, lOglucose and 10 Hepes (pH 7.4 with NaOH, 37’C). 
Solutions E2-E4 contained: 135 or 125 TEA-Cl, 1 MgClr, 10 glucose, 
10 Hepes @H 7.4 with TEA-OH, 37”C), TTX (200 nM) and 1.2 CaCls 
(solution E2) or 10.8 CaClz (solution E3) or 10.8 BaC12 (solution E4). 
Solutions E5-E6 contained: 135 or 125 NaCl, 1 MgCl2, 5.4 CsCl, 10 
glucose, 10 Hepes @II 7.4 with NaOH, 37”C), 200 nM TTX and 1.2 
BaCl2 (solution E5) or 10.8 BaCls (solution E6). Pipette solution 11 
contained (in mM): 90 K-aspartate, 50 KCl, 4 MgClr, 10 Hepes (pH 
7.4 with KOH, 37OC), 3 Nar-ATP and was supplemented with freshly 
prepared nystatin (100 200 fig/ml). I2 contained: 120 CsOH, 120 L- 
aspartate, 20 CsCl, 4 MgClr, 3 Naz-ATP, 10 Hepes (pH 7.4 with 
TEA-OH) and was supplemented with freshly prepared nystatin (100 
200 pg/ml). 13 contained: 100 CsCl, 40 CsOH, 4 MgClr, 3 Nar-ATP, 
10 Hepes @H 7.4 with CsOH, 37’C), 10 EGTA, 6.0 CaClz; the 
calculated free concentration of Ca2+ in this solution was 0.1 PM. 
Published by Elsevier Science Pu~Iishers B. V. ~Biomed~cai Div~s~o~~ 
~145793/~/~3.50  1990 F~eration of European Biochemical Societies 51 
Volume 273, number 1,2 FEBSLETTERS October 1990 
2.5. Statistics 
Data are presented as the meant SE. Statistical significance was 
assessed by the Wilcoxon rank sum test. 
3. RESULTS 
3.1. Secretion experiments 
Table I shows the effects of high Ca*+ and the Ca*+ 
channel agonist Bay K 8644 on CT release from rMTC 
and TT cells. Rising Ca’+ from 1.1 to 2.0 mM or adding 
10 PM Bay K 8644 increased CT secretion from rMTC 
cells but did not affect CT release from TT cells, agree- 
ing with previous reports [6,9]. 
3.2. Spontaneous action potentials 
rMTC cells exhibited resting potentials of -44.5 + 
1.6 mV (n = 38). Rising the Ca*+ concentration from 
1.2 to 1.8 mM elicited spontaneous action potentials 
(Fig. 1 1A) and/or depolarized the cells by 12.1 f 2.3 
mV (n = 9) . The action potentials evoked by high Ca2+ 
could be reversibly suppressed by the Ca2+ channel 
blocker isradipine (PN 200-l 10,l mM) (Fig. 1C). At 1.2 
mM Ca*’ , 1 mM Bay K 8644 often induced a few initial 
spikes but then led to a continuous depolarisation by 
16.3 + 2.9 mV (n= 10). Washing out Bay K 8644 
repolarized the cells (Fig. lE).In contrast, the resting 
membrane potential of TT cells was affected neither by 
high Ca*+ (Fig. 1B) nor isradipine (Fig. 1D) nor Bay K 
8644 (Fig. 1F); their resting potential stayed at - 37.9 
+ 1.8 mV (n= 13). 
3.3. C$’ currents during voltage-clamp steps 
To measure the Ca2’ currents, K+ and Na+ currents 
were blocked with Cs+ , TEA and tetrodotoxin. Under 
these conditions and with 1.2 mM Ca*+ as divalent 
charge carrier, rMTC cells exhibited slowly inactivating 
inward currents (Fig. 2A) which had a maximal current 
density of 9.3 + 0.7 pA/pF (n= 12) at - 10 mV. The 
current-voltage (Iv) relationship revealed a threshold at 
about - 50 mV and an apparent reversal potential at 30 
mV. Increasing the Ca*+ concentration to 10.8 mM 
raised the maximal current 2.5fold and shifted the 
threshold of the Iv-curve to about - 40 mV (data not 
shown). Semilogarithmic plotting of the Ca” current- 
inactivation during depolarisation pulses for 3 s [la] 
revealed two inactivation constants 71 and 72 in rMTC 
Table I 
Effects of Ca*+ and Bay K 8644 on calcitonin secretion. 
Calcitonin release 
rMTC cells TT cells 
(pg.mg protein-‘.h-‘) (ng.mg protein-‘.h-‘) 
Control 126 f 5.8 4.58 f 0.32 
10pM Bay K 8644 229 f 8.0* 4.70 f 0.27”’ 
2 mM Ca*+ 257 f 10.2’ 4.37 f 0.24”’ 
Basal Ca*+ concentration was 1.1 mM. Mean f SEM (n= 5). 
*p<o.o1; “‘not significant to control 
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Fig. 1. Effects of Ca” , a Ca” channel blocker and an agonist on 
membrane potentials in C-cells. The effects of 1.8 CM Ca*+ (Ca) (A 
and B), 1 PM isradipine (PN) (C and D) and 1 CM Bay K 8644 (Bay) 
(E and F) on membrane potentials of rMTC (left) and TT (right) cells 
are shown. The substances were added as indicated by the horizontal 
lines. Solutions: pipette solution 11 and external solution El. External 
solution El with 1.8 instead of 1.2 PM Ca’+ was applied as marked 
in (A) and (B) and throughout in (C) and (D). 
cells. With 1.2 mM Ca2+ and at 37”C, ~1 amounted to 
168 + 11 ms and 72 to 4.9 + 0.7 s (n = 5) for depolarisa- 
tion steps from - 80 to - 10 mV. 
Under 1.2 mM Ca’+, TT cells showed negligibly 
small currents. At 10.8 mM Ca2+ , transient inward cur- 
rents were detectable which completely inactivated 
within about 40 ms (Fig. 2B). Compared to the current 
of rMTC cells, the current density was about 4.5-fold 
smaller and the ZY curve was obviously shifted to the 
left. In agreement with the described properties of the 
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Fig. 2. Whole-cell recordings of Ca*+ currents in C-cells. Original 
current traces of rMTC (A) and TT (B) cells are shown during 300 ms 
long voltage clamp pulses from - 80 mV to various test potentials as 
indicated by the numbers. The membrane patch under the tip of the 
pipette was disrupted and free access to the cytoplasm was obtained. 
Solutions: pipette solution I3 for both rMTC and TT cells; external 
solutions E2 (1.2 CM Ca’+) for rMTC and E3 (10.8 pM Ca*+) for TT 
cells. Vertical and horizontal calibration marks correspond to 30 pA 
and 30 ms. Cell capacity: 12.1 pF (A) and 15.9 pF (B). 
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Fig. 3. Effect of Ba2+ on inward currents in a single rMTC cell at 
various holding potentials. The rMTC cell was voltage-clamped at the 
indicated potentials for 2 min. For the period marked in between the 
vertical arrows Bazc was raised from 1.2 mM (solution E5) to 10.8 
mM (solution E6); pipette solution 12. Horizontal arrows mark the 
zero current level. Calibration marks correspond to 15 s and 20 pA. 
2+ Fig. 4. Effects of Ca channel blockers and an agonist on Ca2+ cur- 
rents in C-cells. The effects of 10 PM Ni2+ (Ni) (A and B), 1 CM 
isradipine (PN) (C and D) and 1 CM Bay K 8644 (Bay) (E and F) on 
currents of rMTC (left) and TT (right) cells are shown. CON refers to 
the controls. Test pulses from - 60 to 0 mV and from - 80 to - 30 
mV were applied to rMTC and to TT cells, respectively. Solutions: 
Pipette solution I3 and external solution E4. Arrows mark the zero 
current level. In (A, C and E), calibration marks correspond to 20 ms 
and 100 pA, in (B, D and F) to 10 ms and 30 pA. 
Cell capacity: 14.3 pF. 
transient T-type Ca” currents [17,18], the threshold 
was about - 60 mV and the maximum (5.1 f 0.5 
pA/pF, n = 9) occurred at about - 30 mV. 
The permeability ratio of Ba2’ /Ca2+ (10.8 mM) 
amounted to 2.1 + 0.2: 1 (n = 5) for Ca2+ channels in 
rMTC cells and to 1.1 f 0.1: 1 (n = 4) for Ca2+ channels 
in TT cells. The midpoint voltage of the steady-state in- 
activation curve of the Ca2+ current as measured with 
10.8 mM Ca2+ was - 24 + 2.5 mV (n = 5) for rMTC 
cells and - 59 + 2.9 mV (n = 4) for TT cells. 
3.4. Effect of Bd’ on inward currents 
[17]. In line with these reports, the fast inactivating 
Ca2+ current of TT cells was inhibited by 65 + 3% 
(n = 5) under 10 PM Ni2+ (Fig. 4B); but the slowly inac- 
tivating current of rMTC cells was not or only minimal- 
ly affected (Fig. 4A). A reverse sensitivity was found in 
the case of dihydropyridines (Fig. 4C-F). Isradipine 
(PN 200-110, 1 PM) suppressed the Ca2+ current of 
rMTC cells by 57 + 5% (n = 6) and the Ca2+ channel 
agonist Bay K 8644 (1 PM) stimulated it by 34 + 4% 
(n = 4). Both isradipine and Bay K 8644 did not affect 
the current of TT cells (n=7). 
To provide direct evidence for a steady-state conduc- 
tivity of Ca2+ channels underlying the Ca2+ sensitivity 
of rMTC cells, we voltage-clamped C-cells at fixed 
holding potentials for several minutes and measured the 
current response to rises of Ba2+ from 1.2 to 10.8 mM. 
At - 40 mV, rMTC cells produced an inward current 
which was maximal (23.0 * 8.6 pA, n = 9) after about 
5 s and then slowly decayed. Fig. 3 3 demonstrates the 
voltage dependence of this inward current for potentials 
between - 60 to 0 mV. The elicited Ba2+ inward current 
displayed a U-shaped voltage dependence with a 
threshold of about - 50 mV. In contrast to rMTC cells, 
TT cells failed to display any inward current in 
analoguous experiments (data not shown). 
4. DISCUSSION 
3.5. Pharmacological characterization 
A major role of dihydropyridine-sensitive Ca2+ cur- 
rents for the Ca2+ sensitivity of C-cells has been sug- 
gested by the effects of Ca2+, organic Ca2’ channel 
blockers and agonists on calcitonin secretion and 
cytosolic Ca2+ concentration in C-cells. (i) The Ca2+ -
induced calcitonin release is blocked by Ca2’ channel 
blockers [4,5, lo]. (ii) The calcitonin release is 
stimulated by Ca2+ channel openers [4,6,10,12]. (iii) 
The intracellular Ca2+ is highly dependent on the ex- 
tracellular Ca2+ concentration [3]. (iv) The intracellular 
Ca2+ rises with Bay K 8644 and falls with nifedipine [6]. 
(v) Increasing the extracellular K+ concentration causes 
a depolarisation, an increase in the cytosolic Ca2+ and 
a subsequent calcitonin release [ 1,3,19]. 
The difference between rMTC and TT cells with 
respect o their Ca2+ currents became more apparent by 
Our electrophysiological studies provide direct 
their different pharmacology. Ni2+ at low concentra- 
evidence for a voltage-dependent, dihydropyridine- 
sensitive, long lasting Ca2+ current in rMTC-cells and 
tions is known to specifically block T-type currents its essential role in the Ca2+ sensitivity of C-cells as 
53 
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evidenced by C-cells of the ‘defective’ TT cell line which 
lack this Ca2+ current and are unable to regulate 
calcitonin secretion in response to Ca2+; the fast inac- 
tivating Ca2+ current that can be detected in TT cells 
fails to substitute as sensor of the extracellular Ca2+ 
concentration. The differing Ca2’ sensitivity of rMTC 
and TT cells cannot be attributed to species differences 
(rat and human, respectively), as normal human C-cells 
and several primary cultures of human C-cell car- 
cinoma have been shown to respond to Cati [10,20,21]. 
To monitor the extracellular Ca2+ concentration, C- 
cells need to have a steady state conductivity for Ca2+. 
Voltage-clamping rMTC cells near their resting poten- 
tial demonstrated a steady state-inward current through 
Ca2+ channels which depended on the concentration of 
the divalent charge carrier. Analyzing the Ca2+ current- 
inactivation we determined a fast (168 ms) and a slow 
inactivation time constant of 4.9 s. With physiological 
Ca2’ concentrations and at 37YJ, inactivation con- 
stants as long as 4.9 s have not been reported for other 
cells 1221, e.g. in cardiocytes, inactivation occurs within 
about 100 ms [23]. Whether the two inactivation time 
constants are due to different inactivated states of the 
Ca2+ channel [24] or the presence of different types of 
Ca2’ channels remains to be evaluated. 
C-cells are known to generate tetrodotoxin- and 
D600-sensitive action potentials [ 19,251. Ca2+ influx 
through dihydropyridine-sensitive Ca2+ channels ap- 
parently plays an important role therein. Increasing 
Ca2+ or adding Bay K 8644 induced action potentials 
and/or depolarized rMTC cells; isradipine suppressed 
the Ca2+ -evoked action potentials. In addition, the 
similarity between the activation threshold of the Ca” 
current and the resting potential of rMTC cells argues 
for a role of the slowly inactivating Ca2+ current in the 
generation of spontaneous activity (compare with [26]). 
T-type Ca2+ currents regarded to be involved in spon- 
taneous activity in other cell types 127,281 were not seen 
in rMTC cells. Moreover, TT cells which exhibited only 
fast inactivating Ca2+ currents did not display spon- 
taneous action potentials. Thus T-type Ca2+ currents 
by themselves eem not to be sufficient to generate 
pacemaking activity. 
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